NCT04805476

Brief Summary

Comorbidities associated with severe obesity determine an important public health problem. Few methods are considered potentially effective for the treatment of severe obesity and the clinical relevance of bariatric surgery is growing, as well as the number of procedures performed. The insertion of the physiotherapist in the multiprofessional team responsible for performing the surgical procedure is essential from the preoperative screening and evaluation to the prevention and treatment of postoperative complications. Therefore, the physiopathological aspects involved with severe obesity, the technical aspects and risks of the surgical procedure, as well as the physiotherapeutic techniques that have scientific proof must be known by the physiotherapist responsible for the surgical follow-up of the patient. In this context, the use of non-invasive ventilation (NIV) in the postoperative period of bariatric surgery has ample therapeutic potential. The present research project aims to evaluate the immediate prophylactic use of NIV on the respiratory and functional recovery of the patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

November 3, 2020

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 18, 2021

Completed
Last Updated

March 18, 2021

Status Verified

March 1, 2021

Enrollment Period

1.2 years

First QC Date

November 3, 2020

Last Update Submit

March 17, 2021

Conditions

Outcome Measures

Primary Outcomes (12)

  • Forced Vital Capacity (FVC)

    Larger volume of air mobilized on an exhalation.

    Preoperative

  • Forced Vital Capacity (FVC)

    Larger volume of air mobilized on an exhalation.

    10 minutes after admission to the recovery room

  • Forced Vital Capacity (FVC)

    Larger volume of air mobilized on an exhalation.

    1 hour after admission to the recovery room

  • Forced expiratory volume in one second (FEV1)

    Volume of air exhaled in the first second during the FVC maneuver.

    Preoperative

  • Forced expiratory volume in one second (FEV1)

    Volume of air exhaled in the first second during the FVC maneuver.

    10 minutes after admission to the recovery room

  • Forced expiratory volume in one second (FEV1)

    Volume of air exhaled in the first second during the FVC maneuver.

    1 hour after admission to the recovery room

  • FEV1/FVC ratio

    Ratio between forced expiratory volume in the first second and vital capacity.

    Preoperative

  • FEV1/FVC ratio

    Ratio between forced expiratory volume in the first second and vital capacity.

    10 minutes after admission to the recovery room

  • FEV1/FVC ratio

    Ratio between forced expiratory volume in the first second and vital capacity.

    1 hour after admission to the recovery room

  • Peak expiratory flow (PEF)

    Maximum air flow during the FVC maneuver.

    Preoperative

  • Peak expiratory flow (PEF)

    Maximum air flow during the FVC maneuver.

    10 minutes after admission to the recovery room

  • Peak expiratory flow (PEF)

    Maximum air flow during the FVC maneuver.

    1 hour after admission to the recovery room

Study Arms (2)

Non invasive mechanical ventilation

EXPERIMENTAL

The subjects in the immediate intervention group (GI) will be extubated and placed in NIV the moment they enter the recovery room through a portable ventilator (Esprit ® or BiPAP Vision ®, Respironics) in face mask. The parameters will be adjusted as follows: FiO2 = 50%, positive expiratory pressure (EPAP, starting at 4-6 cmH2O and adjusting 1-2 cmH2O to avoid snoring, apnea, paradoxical breathing and desaturations) and adjusted inspiratory positive pressure (IPAP) to maintain a tidal volume of 400 to 500 ml, maintaining IPAP \<15cmH2O17. Individuals will receive this ventilatory support for 1 hour. After this period the patients will be submitted to the same care of GP patients.

Device: Non invasive mechanical ventilation

Usual care

ACTIVE COMPARATOR

Subjects will receive oxygen therapy through a nasal cannula with 4 to 6 L / min of oxygen according to the team routine and patient need.

Device: GP

Interventions

Prophylactic non invasive mechanical ventilation

Non invasive mechanical ventilation
GPDEVICE

GP subjects will receive oxygen therapy through a nasal cannula with 4 to 6 L / min of oxygen according to team routine and patient need.

Usual care

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients undergoing bariatric surgery

You may not qualify if:

  • Absolute or relative contraindications to the use of NIV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Location

MeSH Terms

Conditions

Obesity, MorbidHypoventilation

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsRespiratory InsufficiencyRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, Respiratory

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Fábio Di Naso, PhD

    Federal University of Rio Grande do Sul

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2020

First Posted

March 18, 2021

Study Start

March 1, 2017

Primary Completion

May 31, 2018

Study Completion

July 31, 2018

Last Updated

March 18, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations